how do glp 1 drugs make you lose weight loss – hope or hype? 4 facts about GLP-1 weight
Description
The most common risks of oral GLP-1s like Rybelsus, Wegovy pill, and Foundayo include : Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All three GLP-1s also carry a black box warning for thyroid tumors based on animal studies
What Is Retatrutide Retatrutide is Eli Lilly's experimental drug for obesity and related conditions
As you can see, most marketed biosimilars are excluded from the larger PBMs 2025 formularies
Experimental studies have shown that GLP-1 RAs can reverse early retinal changes associated with DR, restoring blood-retinal barrier integrity and preventing retinal cell death
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes
Randomized clinical trials would be needed to prove that GLP-1s could slow cancer progression
